Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma

NCT00944567 is registered in ClinicalTrials.gov with International Extranodal Lymphoma Study Group (IELSG) as lead sponsor.

NCT NCT00944567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00944567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinico-Pathologic Study of Primary Mediastinal B-Cell Lymphoma
Lead sponsor
International Extranodal Lymphoma Study Group (IELSG)
Phase
Observational
Overall status
Completed
Start date
January 31, 2007
Completion date
February 27, 2017
Enrollment
125 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

primary mediastinal b-cell lymphoma